Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karen Shoos Lipton currently holds 41,833 shares of Celldex Therapeutics, Inc. (CLDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Shoos Lipton has been a net seller of CLDX stock. They have purchased $11.2K and sold $434.3K worth of shares.
Karen Shoos Lipton's most recent insider trade was on Jun 15, 2017, when they sold 10,000 shares at $0.00 per share.
Karen Shoos Lipton serves as Executive at Celldex Therapeutics, Inc. (CLDX). They have executed 13 insider transactions totaling $445.6K over their tenure at the company.
Karen Shoos Lipton holds the position of Executive at Celldex Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Karen Shoos Lipton has shown a selling trading pattern, with $11.2K in total purchases and $434.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karen Shoos Lipton was on Dec 6, 2013, when they sold $434.3K worth of CLDX shares. This transaction involved 17,728 shares at $24.50 per share.
Karen Shoos Lipton currently owns 41,833 shares of Celldex Therapeutics, Inc. (CLDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karen Shoos Lipton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karen Shoos Lipton has 13 Form 4 filings on record as an insider at Celldex Therapeutics, Inc..
Set alerts for Karen Shoos Lipton and 40,000+ other insiders.